Financial Review: SBC Medical Group (NASDAQ:SBC) and AirSculpt Technologies (NASDAQ:AIRS)

SBC Medical Group (NASDAQ:SBC) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation and institutional ownership.

Earnings and Valuation

This table compares SBC Medical Group and AirSculpt Technologies”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SBC Medical Group	$223.34 million	2.79	$340,000.00	N/A	N/A
AirSculpt Technologies	$188.78 million	1.64	-$4.48 million	($0.14)	-38.21

SBC Medical Group has higher revenue and earnings than AirSculpt Technologies.

Profitability

This table compares SBC Medical Group and AirSculpt Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SBC Medical Group	N/A	-11.59%	-7.05%
AirSculpt Technologies	-4.13%	2.22%	0.90%

Volatility and Risk

SBC Medical Group has a beta of 0.2, meaning that its stock price is 80% less volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for SBC Medical Group and AirSculpt Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SBC Medical Group	0	0	0	0	0.00
AirSculpt Technologies	0	4	0	0	2.00

AirSculpt Technologies has a consensus price target of $5.00, suggesting a potential downside of 6.54%. Given AirSculpt Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe AirSculpt Technologies is more favorable than SBC Medical Group.

Insider and Institutional Ownership

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are owned by institutional investors. 63.9% of SBC Medical Group shares are owned by company insiders. Comparatively, 78.8% of AirSculpt Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

AirSculpt Technologies beats SBC Medical Group on 7 of the 11 factors compared between the two stocks.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.

About AirSculpt Technologies

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas. The company’s body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.